A novel crosstalk between TRPM7 and O-GlcNAcylation was uncovered and their molecular targets for controlling NSCLC motility were subsequently identified as Cav-1 and c-Myc. The gene discussed is CAV1; the disease is non-small cell lung carcinoma.